sysa1801
cspc pharmaceuticals,elevation oncology
[]
$elev pre #asco23 gains definitely not holding (currently off 22%). i quite liked the data though... 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.